{"description":"18 July 2018 ASA Ruling on Elle Fox t/a Bubbling Life https://www.asa.org.uk/rulings/elle-fox--a18-443476.html \u81ea\u9589\u30b9\u30da\u30af\u30c8\u30e9\u30e0\u75be\u60a3\u306bCEASE\u7642\u6cd5\u3001ADHD/ADD\u3084\u6162\u6027\u75b2\u52b4\u75c7\u5019\u7fa4\u7b49\u306bGAPS\u7642\u6cd5\u3092\u85a6\u3081\u308b\u4ee3\u66ff\u7642\u6cd5\u6a5f\u95a2\u3002\u6839\u62e0\u306b\u3064\u3044\u3066\u306e\u7167\u4f1a\u306b\u5bfe\u3057\u3066General Regulatory Council for Complementary Therapies (GRCCT).\u306b\u8a8d\u8a3c\u3055\u308c\u3066\u3044\u308b\u3068\u3060\u3051\u56de\u7b54\u3002\u5e83\u544a\u57fa\u6e96\u9055\u53cd","blog_url":"https://uneyama.hatenadiary.jp/","type":"rich","height":"190","published":"2018-07-18 00:00:06","width":"100%","provider_name":"Hatena Blog","url":"https://uneyama.hatenadiary.jp/entry/20180718/p7","author_url":"https://blog.hatena.ne.jp/uneyama/","categories":["ASA"],"version":"1.0","image_url":null,"author_name":"uneyama","provider_url":"https://hatena.blog","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","title":"ASA\u88c1\u5b9a","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20180718%2Fp7\" title=\"ASA\u88c1\u5b9a - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>"}